The BOLERO-2 study confirms everolimus and exemestane in ER/PR+ advanced breast cancer improves PFS

Genetic basis of cancer predisposition

4HBR chemoprevention in BRCA positive women

Frequency of biopsies for breast cancer tumours

Experimenting with smaller, faster clinical trials

Zoledronic acid reduces recurrence of breast cancer

Denosumab delays metastases for prostate cancer

Radiotherapy between or during chemo cycles for breast cancer

Trastuzumab emtansine, Phase II trial for HER2

Genetic mutations as causes of cancer

Cost effective ways to predict prostate cancer 1/2

Cost effective ways to predict prostate cancer 2/2